VJOncology is committed to improving our service to you

Share this video  

VJOncology is committed to improving our service to you

AACR 2021 | Future targets for pancreatic cancer treatment

Michael Kim, MD, The University of Texas MD Anderson Cancer Center, Houston, TX, discusses the future of treatment for pancreatic cancer, highlighting potential targeting of pathways impacted by mutant p53 or oncogenic KRAS, such as CREB1, to prevent metastasis. This interview took place at the virtual American Association for Cancer Research (AACR) Annual Meeting 2021.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter